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INTRODUCTION
Lead is the second most hazardous substanceaccording to priority list of hazardous substances byAgency of Toxic Substance and Disease Registry(ATSDR).1,2 It has no physiological role and is ubiquitousin the environment, leading to clinical and subclinicaltoxicity primarily through ingestion and inhalation.3,4Between the two, more lead is absorbed into thecirculation by inhalation (50-70%) compared to ingestion(adults 10%, children 40-50%). In addition to environmentalexposure, there are occupations that can potentiallycause lead exposure to workers.5
Understanding of lead toxicity has advancedconsiderably over the past years, and emphasis hasshifted from toxicity effects in clinically symptomaticpatients to the consequences of low exposure causingmild or no symptoms.6 The availability of more sensitiveanalytical methods has made it possible to measure leadat much lower concentrations.7 In 1991, the Centers forDisease Control and Prevention (CDC) redefined the
cutoff value of elevated BLL in children from <25 µg/dLto <10 µg/dL and then lowered to 5 µg/dl in 2012, basedon current BLL and accumulating scientific evidence oflead related adverse health effects.8 In 2009 September,Germany set 3.5 µg/dL as the goal for children (up to theage of 12 years) and for men and women currently9 µg/dL and 7 µg/dL, respectively for BLL based on the95th percentile of results of national blood lead surveys.9Researchers propose that public health action lead levelof 2 g/dL to replace 10 g/dL for children due toscientific, economic, and public health considerations.10
The environmental efforts, most importantly the phasingout of lead from gasoline, have been shown todramatically reduce the prevalence of lead poisoning incountries like US, United Kingdom and Mexico withreported decrease in BLL.11 Pakistan government in2001 encouraged all the refineries in the country tophase out lead in petrol with permissible petroleum leadlimit of 0.02 g/l, which was completed in July 2002.12There is paucity of data on lead toxicity in Pakistanichildren after phasing out of leaded petroleum, so thisstudy primarily aimed to determine the frequency ofsubclinical lead toxicity in our setting.
METHODOLOGY
Analysis of laboratory data for patients tested for plasmalead from January 2011 to December 2014 was done atthe Section of Chemical Pathology, Department of
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Pathology and Laboratory Medicine, The Aga KhanUniversity Hospital, Karachi. For all subjects, only initialtest results were included while the results of repeatedtesting were excluded. To maintain confidentiality,patients’ identification were deleted and code wasassigned. Exemption was sought from institutionalethical review committee.
Whole blood lead levels were performed by graphitetube atomizer, atomic absorption spectrometer 200series AA (Agilent Technologies, California, US). Three-level quality control materials were run with each batchof samples. The laboratory participated in proficiencytesting survey of College of American Pathologist twicea year with >80% performance when compared withpeer group.
Adult subjects were categorized into three groups basedon BLL as groups I, II, and III with BLL <10 ug/dl, 10-70ug/dl and >70 ug/dl, respectively. The blood leadgroupings in children were done at cutoff value of<2 ug/dl, 2-10 ug/dl and >10 ug/dl. In adults levels of10-70 ug/dl and 2-10 ug/dl, and in children were takenas subclinical lead toxicity.10
The statistical analysis was performed using the SPSSversion 19. Normality of data distribution was assessedby Shapiro-Wilk test. Median and interquartile ranges ofage, and BLL, while frequency of gender and BLLgroups were derived.
RESULTS
Five hundred and twenty-four subjects underwent BLLtesting over a period of 36 months at the ClinicalLaboratory. Among the 524 subjects, 424 (81%) weremales and median age of the subjects was 27 (37-15)years. Out of the total 26.5% (n=139) were children (age<16 years) while rest were adults. The data was skewed(p<0.001).
Overall median BLL was 6.4 (20.9-3.1) ug/dl. Themedian BLL were 4 (8-3) ug/dl in children with only 16%(n=22) of the children had desirable BLL and most ofthem either had subclinical lead toxicity or toxic BLL;shown in Table I. The overall median BLL in adults were8.3 (27.9-3.4) ug/dl with majority of subjects having
normal BLL, while 4.99% (n=19) had BLL >70 ug/dl,warranting treatment initiation (Table I). Higher BLL wereobserved in subjects with age range 21 to 30 years[median lead level=16.9 ug/dl (36.1-4)] and lower levelswere observed in younger age groups with lowest BLL[4.2 ug/dl (6.8-2.6)] in children with <10 years of age.Figure 1 shows the median BLL distribution in differentage groups.
DISCUSSION
The major finding of this study is high median BLL inboth children and adults, which is a public healthconcern. There is limited data on lead toxicity burdenafter phase out of leaded petroleum in Pakistan.Previous studies on Pakistani population have reportedhigher mean BLL; a study by Khan, et al. reported meanBLL in children as 7.9 ug/dl and elevated BLL (>10 ug/dl)in 25% children.13 While another population-based studyby Rahbar, et al. reported 15.6 ug/dl mean lead levels inchildren with elevated BLL in 80% of children.14 Acommunity-based survey of school children, conductedby Manser, et al. reported very high mean BLL (>40 ug/dl)with nearly 92% children having elevated BLL.15 Thesestudies were done before phase out of lead in petrol inPakistan.16-18 So compared to the present study, highprevalence of elevated BLL in previously reportedliterature is understandable (Table II). In the presentstudy, it was observed that considerable decline in BLLhas occurred over the past decade, reducing the
Table I: Lead level distribution of subjects tested for blood lead levelsfrom 2011 to 2014. (n=524).
Blood lead levels Frequency (%) Lead levels (ug/dl)
Median (IQR)
Children of <16 years (n=139)
Desired level (<2 ug/dL) 22 (16) 1.8 (2-1.27)
Subclinical lead toxicity (2-10 ug/dL) 106 (76) 4.3 (6.4-3.17)
Elevated levels (>10 ug/dl) 11 (8) 13.8 (20.9-11.2)
Adults of >16 years (n=385)
Desired level (<10 ug/dL) 212 (55) 3.7 (6.3-2.32)
Subclinical lead toxicity (10-70 ug/dL) 154 (40) 27.9 (48.6-20.2)
Elevated levels (>70 ug/dl) 19 (4.9) 83.6 (87.7-73.5)
Table II: Comparison of BLL in children reported by similar studies fromour region.
Study Present study Rahbar et al.10 Khan et al.9 Manser et al.11
Study year 2011-2014 Aug-Dec Jun-Aug 19902000 1997
Number of subjects 139 400 119 190
Age (years) 5 (8-3) 3.45 (4) 6.4 9 (4-18)
BLL (ug/dl) 4 (6.7-2.6) 15.6 7.9 ±4.5 38 ±14.35(median in <16 years)
Lead toxicity 8% 80% 25.2% 92% had BLL >10 ug/dl (BLL >40 ug/dl)
Figure 1: Distribution of median blood lead levels across different agegroups.
frequency of high BLL in children. A decline in frequencyof children with BLL >10 µg/dL is obvious, from 80% to8% (Table II). However, the median BLL is still high inchildren 4 (6.7 - 2.6 µg/dl). Present study also reporthigh prevalence of subclinical toxicity (76%, n=106) inchildren, and most of them under 16 years of age, theage range 3 to 12 years (n=68). On comparing thisstudy's findings with US National Health and NutritionExamination Survey (NHANES) of lead exposure inchildren, BLL in Pakistani children are comparablyhigher. But these findings should be interpreted bykeeping in mind that lead was phased out frompetroleum products in 1970s in US and since thenvigorous primary prevention strategies were adopted toreduce lead exposure.19
The observed BLL for adults in this study was also highwith higher levels in 21-30 years and decreasing levelswith increasing age with subclinical lead toxicityobserved in one-fourth of the adults. A case control studydone by Rahman, et al. on Pakistani adults reportedhigher BLL in hypertensive patients, with mean BLL13.9 ug/dl (range 78 - 201 ug/dl) and 25.5 ug/dl (Range165-497 ug/dl) in normal and hypertensive adults,respectively.20
There is limited information available regarding thestatus of lead in Pakistani children. The present studyhas provided us with insight into the current statusregarding BLL in Pakistani population. These findingssuggest that steps should be taken to reduce exposure,especially in children to avoid health risks associatedwith low levels of lead exposure because there appearsto be no threshold for these effects.21,22 The limitationsof this study were that complete clinical information ofthe subjects could not be gathered as it was a retro-spective analysis including a large percentage of outsidereferrals, so the study group is not representative of thegeneral population and larger community-based studiesare required for the confirmation of our findings.
CONCLUSION
This study highlights that BLLs have lowered after phaseout of leaded petroleum from Pakistan, which is a majorpublic health success in primary prevention efforts.However, lead exposure at levels that may adverselyaffect the health of children still remains. Strategies toidentify the sources of lead exposure and eradicating/controlling such sources be planned; and publicawareness should be raised via different media,regarding sources of lead exposure, their impact onhealth and measures to reduce the exposure, especiallyin children.
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